U.S. Glaucoma Pharmaceuticals Market

U.S. Glaucoma Pharmaceuticals Market published by Frost & Sullivan in March, 2009. This report consists of 77 Pages and the price starts from US $ 6000.

Introduction

Abstract

This research service explores the market for prescription ophthalmics used for the treatment of glaucoma in the United States of America. It analyzes the various challenges faced by pharmaceutical and biotech companies, and the competitive advantages and disadvantages of their products in the market.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

• Overview

2. U.S. GLAUCOMA PHARMACEUTICALS MARKET

Research Scope and Methodology

• Scope and Segmentation
• Research Methodology

Market Overview

• Introduction
• Disease Overview

Patient Forecasts

• Ocular Hypertension
• Open-Angle Glaucoma

Market Trends

• Industry Challenges and Strategies
• Market Drivers

3. PRODUCT AND PIPELINE ANALYSIS

Approved Therapies and Treatment Overview

• Treatment Overview
• Prostaglandin Analogues
• Beta-Blockers
• Combination Therapies
• Carbonic Anhydrase Inhibitors
• Alpha Adrenergic Agonists

Pipeline Analysis

• Glaucoma Pipeline

4. COMPETITIVE ANALYSIS

Introduction

• Market Engineering Measurements
• Price Trends
• Competitive Structure

Market Share and Revenue Forecasts

• Market Share
• Revenue Forecast

5. APPENDIX

Decision Support Databases

• Total Population
• Population Aged 65 and Up
• Glaucoma Prevalence
• Glaucoma Incidence
• Glaucoma Drugs in Clinical Trials

Related Reports